Sleep Apnea and Heart Failure
Top Cited Papers
- 8 April 2003
- journal article
- review article
- Published by Wolters Kluwer Health in Circulation
- Vol. 107 (13) , 1822-1826
- https://doi.org/10.1161/01.cir.0000061758.05044.64
Abstract
In the first part of this 2-part review, we provided a synopsis of the cardiovascular effects of normal sleep and an overview of the diagnostic, pathophysiological, and therapeutic implications of obstructive sleep apnea (OSA) in the setting of heart failure (HF). In this second part, we turn our attention to central sleep apnea (CSA), commonly referred to as Cheyne-Stokes respiration. This breathing disorder has a strikingly higher prevalence in patients with HF as compared with the general population with normal left ventricular function, and when present appears to have adverse prognostic implications. Our objective in Part II of this review is to provide a broad perspective of the pathophysiological and clinical significance of CSA in HF. CSA associated with Cheyne-Stokes respiration is a form of periodic breathing in which central apneas and hypopneas alternate with periods of hyperventilation that have a waxing-waning pattern of tidal volume. Figure 1 illustrates the proposed mechanisms that underlie periodic oscillations in ventilation in HF. Unlike OSA, CSA likely arises as a consequence of HF. Thus, the presence of CSA may alert the physician to the necessity of intensifying HF therapy. The current debate is whether CSA is simply a reflection of severely compromised cardiac function with elevated left ventricular filling pressures, or whether, for the same degree of cardiac dysfunction, CSA exerts unique and independent pathological effects on the failing myocardium. Although there are not yet sufficient data to resolve this controversy within the confines of this review, we will discuss evidence on both sides of this issue. Figure 1. Pathophysiology of central sleep apnea in heart failure (HF). HF leads to increased left ventricular (LV) filling pressure. The resulting pulmonary congestion activates lung vagal irritant receptors, which stimulate hyperventilation and hypocapnia. Superimposed arousals cause further abrupt increases in ventilation and drive PaCO2 …Keywords
This publication has 50 references indexed in Scilit:
- Sleep Apnea and Heart FailureCirculation, 2003
- Oscillatory Breathing Patterns During Wakefulness in Patients With Chronic Heart FailureCirculation, 1999
- A Mechanism of Central Sleep Apnea in Patients with Heart FailureNew England Journal of Medicine, 1999
- Effect of Theophylline on Sleep-Disordered Breathing in Heart FailureNew England Journal of Medicine, 1996
- Detection and significance of a discrete very low frequency rhythm in RR interval variability in chronic congestive heart failureThe American Journal of Cardiology, 1996
- Improvement of exercise capacity with treatment of Cheyne-Stokes respiration in patients with congestive heart failureJournal of the American College of Cardiology, 1996
- The epidemiology of heart failure: The Framingham StudyJournal of the American College of Cardiology, 1993
- Obstructive sleep apnoea in patients with dilated cardiomyopathy: effects of continuous positive airway pressureThe Lancet, 1991
- Diurnal variation of pulmonary artery pressure in chronic heart failure.Heart, 1989
- Control of Breathing During SleepPublished by American Geophysical Union (AGU) ,1986